Market Tracker

04/24 6:02pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

120.28
Delayed Data
As of Apr 24
 -2.67 / -2.17%
Today’s Change
55.36
Today|||52-Week Range
133.54
+33.05%
Year-to-Date

Today’s Trading

Previous close122.95
Today’s open122.38
Day’s range120.21 - 123.14
Volume821,847
Average volume (3 months)1,517,068
Market cap$19.6B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+28.13%
Earnings growth (this year)-146.57%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+36.76%
P/E ratioNM
Price/Sales17.64
Price/Book12.00

Competitors

 Today’s
change
Today’s
% change
PCYCPharmacyclics Inc-0.51-0.20%
INCYIncyte Corp-0.51-0.47%
ENDPEndo International P...-0.81-0.86%
ZTSZoetis Inc+0.86+1.83%
Data as of 4:04pm ET, 04/24/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$750.0M
Annual profit (last year)-$134.0M
Net profit margin-17.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts